Effects of inhaled nitric oxide on ventilation/perfusion mismatch assessed by electrical impedance tomography in patients with ARDS: a prospective observational study

吸入一氧化氮对ARDS患者通气/灌注失衡的影响:一项前瞻性观察研究(采用电阻抗断层扫描技术评估)

阅读:1

Abstract

BACKGROUND: Our study aimed to assess the effects of inhaled nitric oxide (iNO) on ventilation/perfusion mismatch, and individual variability in patients with acute respiratory distress syndrome (ARDS) by electrical impedance tomography (EIT). METHODS: This single-center, prospective physiological study enrolled mechanically ventilated ARDS patients. All patients initially received 5 ppm iNO; responders (≥ 20% increase in PaO(2)/FiO(2) at 30 min) maintained this dose, while non-responders had their dose doubled every 30 min, up to 40 ppm, until achieving a ≥ 20% improvement. The trial lasted 3 h. EIT data and clinical respiratory and hemodynamic parameters were collected at baseline (0 h), and at 30 min and 3 h after iNO initiation. RESULTS: At 30 min, 36.7% (11/30) of patients responded, associated with younger age and lower prevalence of hypertension. Among responders, the proportion of ventral perfusion significantly increased at 3 h, with this change already observed at 30 min. Responders also showed a significant reduction in the proportion of only perfused units in the dorsal region at 30 min; at the whole-lung level, the proportions of only perfused units and unmatched units decreased. In contrast, non-responders showed an increased proportion of only perfused units in both the dorsal region and whole lung at 3 h compared to baseline, following prolonged high-dose iNO administration. CONCLUSIONS: The response to iNO varied. In responders, EIT showed a potential redistribution of lung perfusion toward ventral regions, with reductions in the proportions of only perfused units and unmatched units in the whole lung.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。